TSS Clinical Trials Digitalization User Forum 2021
Document
We’re pleased to announce the first TSS Clinical Trials Digitalization User Forum on February 10-11, 2021
How can digitalization transform trials while maintaining quality standards that ensure safe medicine?
What is on this page?
Click to jump to a specific section below.
Digitalization to transform clinical trials to ensure a safe drug to every patient
Together with our most valued partners, we are hosting two half-day virtual sessions with interactive content addressing value-adding digital transformation in clinical trials.
This by-invitation-only user forum set out to discuss best practices for streamlining clinical trial costs and efforts by utilizing digital technologies while moving more towards a patient-centered trial experience.
Some of the topics discussed during the forum were:
- Leveraging IoT to transform clinical trials and lower costs in 2021
- Ensuring a safe drug to every patient with Digital health and Remote inspections
- Creating a holistic end-to-end view that drives sustainability and reduces waste
- Transforming the future. New solutions available
In case you would like to get more information about the event, please contact us.
You may also be interested in
White paper: the future, today - the next generation of temperature monitoring
New technologies for tracking and temperature logging hold great potential, but which to choose? Get a copy of our latest white paper.
Read moreDownload Whitepaper
Covid-19 situation
The effects of the Covid-19 outbreak are escalating daily and is first and foremost a human tragedy, affecting hundreds of thousands of people.
Read moreDownload Whitepaper
On-demand webinar: Master your supply chain with end-to-end visibility
Learn how one of the world’s largest pharma organisations saves millions of dollars and thousands of tonnes of CO2 with a clean, simple, and efficient supply chain.
Read moreDownload WhitepaperYou may also be interested in
TSS Receives CDP SME Climate Score 'SME B' for Strong Climate Actions
TSS, a global company specializing in temperature monitoring for the pharmaceutical supply chain, is proud to announce that it has received an 'SME B' rating from the 2024 CDP SME Climate Score. This recognition highlights TSS’s commitment to being open about its environmental impact and taking steps to reduce it.
Read more
TSS Keeps EcoVadis Silver Medal Despite Tougher Standards in 2024
TSS, a leading provider of temperature-monitoring solutions for the life-science industry, proudly announces that it has retained the EcoVadis Silver Medal for the second consecutive year. This recognition is a testament to TSS’s ongoing commitment to sustainability, even as EcoVadis raised the bar for its assessment criteria in 2024.
Read more